March 2018 FDA Recall Hydrocodone Bitartrate And Homatropine Methylbromide by Novel Laboratories, Inc.
D-0599-2018 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Novel Laboratories, Inc. on March 5, 2018 for the product Hydrocodone Bitartrate And Homatropine Methylbromide. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0599-2018

Reason for Recall
Failed Impurities/Degradation Specifications
Initiated
03-05-2018
Reported
03-21-2018
Quantity
134,364 bottles (4,030,920 tablets)

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Novel Laboratories, Inc.
Lupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1.5 mg Rx Only 30 Tablets Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-118-03 UPC 343386118038

Batch or Lot Expiration Information

Lot# M16002A (02/2018); M16246A (04/2018); M16246B (04/2018); M16434A (07/2018); M16569A (10/2018); M17015A (01/2019); S700271 (04/2019)